Page last updated: 2024-09-04

birb 796 and as1940477

birb 796 has been researched along with as1940477 in 1 studies

Compound Research Comparison

Studies
(birb 796)
Trials
(birb 796)
Recent Studies (post-2010)
(birb 796)
Studies
(as1940477)
Trials
(as1940477)
Recent Studies (post-2010) (as1940477)
137580505

Protein Interaction Comparison

ProteinTaxonomybirb 796 (IC50)as1940477 (IC50)
Mitogen-activated protein kinase 13Homo sapiens (human)0.011
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)0.036
Mitogen-activated protein kinase 11Homo sapiens (human)0.036

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, T; Harayama, Y; Kasahara, C; Kinoshita, T; Kontani, T; Kubota, H; Misumi, K; Mizuhara, H; Ohno, K; Ohta, M; Takeuchi, M; Yamazaki, H; Yokomoto, M1

Other Studies

1 other study(ies) available for birb 796 and as1940477

ArticleYear
Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitor.
    Journal of medicinal chemistry, 2012, Sep-13, Volume: 55, Issue:17

    Topics: Biological Availability; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors

2012